# Orphenadrine Citrate, Aspirin and Caffeine

NDC: 71993-304
Generic name: Orphenadrine Citrate, Aspirin and Caffeine
Labeler / Manufacturer: Atland Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220318

FDA application: ANDA075141

## Active ingredients

- ASPIRIN: 385 mg/1
- CAFFEINE: 30 mg/1
- ORPHENADRINE CITRATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71993-304"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71993-304
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61ca2af1-081c-411c-90ce-ec6d9e3157b2